Hypothesis: thalidomide embryopathy-proposed mechanism of action.
about
Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formationThalidomide-induced teratogenesis: history and mechanismsThe treatment of advanced renal cell cancer with high-dose oral thalidomideBiology-inspired microphysiological system approaches to solve the prediction dilemma of substance testingA HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases.Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma.Thalidomide-a notorious sedative to a wonder anticancer drug.Thalidomide: the tragedy of birth defects and the effective treatment of disease.Teratogenic effects of thalidomide: molecular mechanisms.Teratogen-induced limb defects.Thalidomide and its derivatives: emerging from the wilderness.Thalidomide: a new anticancer drug?Managing pregnant women with cancer: personal considerations and a review of the literature.Shoulder joint replacement can improve quality of life and outcome in patients with dysmelia: a case series.Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis.Thalidomide: dermatological indications, mechanisms of action and side-effects.NF-κB pathway in colitis-associated cancersDeciphering the mystery of thalidomide teratogenicity.Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy.Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders.Prenatal exposure to environmental factors and congenital limb defects.The role of epigenetics in the induction of fetal hemoglobin: a combination therapy approach.The effect of thalidomide in chicken embryos.Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.Offspring of male and female parents with thalidomide embryopathy: birth defects and functional anomalies.A requirement of nuclear factor-kappaB activation in fear-potentiated startle.PBX, MEIS, and IGF-I are potential mediators of retinoic acid-induced proximodistal limb reduction defects.Of meis and men: lessons from a microarray study of teratogen action.Thalidomide Embryopathy: An Enigmatic Challenge
P2860
Q24653215-19395DDE-687A-4880-93DA-9576E53B0B2CQ28085087-45F85879-9753-4A78-874A-E28C02BBC9C2Q28361231-39944616-7771-4D38-8DF5-40E6A67173EBQ30358385-EC444DD0-42E2-4FFF-A58C-E91BC3F1E1D3Q33683998-BD912F22-4E0B-4121-9A68-773C0D6836C9Q33880085-8699CC17-313F-4FC7-B8D0-3B1B6E804E01Q33956871-186C77BB-0DA6-44A2-A8A6-0182E35707F4Q34179690-E68CC04D-2D57-4F43-BB2D-19D91EE1C520Q34660391-0FB807CB-DF14-4EFA-83E0-D2D47BA60587Q34926892-7AF47684-1FED-4DB6-B6EC-26C1B7C7F95CQ35107977-641BF8CB-0E2D-4310-BB22-5588C03F13A2Q35164773-7F504B66-BE1B-469D-8AEF-B8897FB6FCB6Q35572759-30D996BF-A68B-49AC-8C85-363B5EF14FA4Q36000164-11C609B1-E1F4-4F10-866A-172A96CF76C8Q36059602-363BB6D8-9633-4367-B861-98094EAEB820Q36222128-1E53A34A-79A8-4C14-832B-72593D224C1BQ36795773-8F74F7CF-AF8D-4267-AF0A-3BFA3689928BQ37986238-E052E7EA-ED1D-4D13-9C30-227B351E8289Q38085053-8DF2E082-2364-4B34-967E-026B4BC74944Q38186032-D036157D-F60E-4DAB-A92C-F82125B2C784Q38987429-768F2AAF-0E47-4D4E-B288-7AB62DC1CD80Q41911650-1B5D212C-A056-42B3-8175-B0F6C833FD45Q41994803-7C401563-6E15-4E0D-8597-B3BA7999B446Q44041377-235A4670-EBA3-4911-92B1-BECDA406E780Q44124753-EB2F8EB6-9724-4637-B313-E164FB4B38AEQ44155950-F23790A6-B7C5-4832-932C-BEDD4FFD5610Q44192501-1B0E454F-6E57-4279-9207-C45EEE5D050AQ52029882-B3F6BA8C-AA1B-4BD8-83F4-994B40E4ED72Q57129133-613B3667-9C81-4625-9E90-4F80A612C95A
P2860
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@ast
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@en
type
label
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@ast
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@en
prefLabel
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@ast
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@en
P2860
P1476
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
@en
P2093
Fillmore BJ
Stephens TD
P2860
P304
P356
10.1002/(SICI)1096-9926(200003)61:3<189::AID-TERA6>3.0.CO;2-W
P577
2000-03-01T00:00:00Z